Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Infectious diarrhea].

C Mottet1, A A El Wafa, M Cavassini

  • 1Service de gastro-entérologie et d'hépatologie, BH10N, Lausanne.

Revue Medicale Suisse
|March 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same author

Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.

HIV medicine·2021
Same author

Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission.

HIV medicine·2020
Same author

Causes of fever in Tanzanian adults attending outpatient clinics: a prospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Authors' reply to A. Winston, A. Cotter, M. Gisslen, P. W. G. Mallon and P. Cinque.

HIV medicine·2020
Same author

How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?

HIV medicine·2019
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Traveler's diarrhea usually resolves within 48 hours. For chronic diarrhea in HIV patients, a diagnostic workup and targeted treatment are essential, with highly active antiretroviral therapy (HAART) crucial for specific infections.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Public Health

Context:

  • Traveler's diarrhea is a common, self-limiting illness.
  • Chronic diarrhea in HIV-positive individuals has evolved with modern treatments.
  • Management strategies differ significantly between acute traveler's diarrhea and chronic diarrhea in immunocompromised patients.

Purpose:

  • To provide guidance on managing traveler's diarrhea.
  • To outline the diagnostic and therapeutic approach for chronic diarrhea in HIV-positive patients.
  • To emphasize the role of highly active antiretroviral therapy (HAART) in specific opportunistic infections.

Summary:

  • Traveler's diarrhea typically requires symptomatic management and attention to hydration, with prophylactic or routine antibiotic use generally not advised.

Related Experiment Videos

  • Chronic diarrhea in HIV patients, especially when not linked to HAART initiation, necessitates a thorough diagnostic investigation including stool analysis and endoscopic procedures.
  • Treatment focuses on identifying and eradicating specific pathogens, with HAART being a cornerstone for managing microsporidiasis and cryptosporidiosis in this population.
  • Impact:

    • Informed clinical decision-making for acute and chronic diarrheal diseases.
    • Improved patient outcomes through targeted management strategies.
    • Reduced unnecessary antibiotic use for traveler's diarrhea, potentially mitigating antimicrobial resistance.